Related Experiment Videos
[Interstitial brachytherapy in malignant gliomas].
1Dept. of Neurosurgery, Univ. of California, San Francisco.
Gan No Rinsho. Japan Journal of Cancer Clinics
|September 1, 1989
Summary
Interstitial brachytherapy offers precise radiation for brain tumors, improving survival for recurrent malignant gliomas compared to chemotherapy. This advanced treatment allows higher doses and reirradiation.
Area of Science:
- Oncology
- Neurosurgery
- Radiation Oncology
Context:
- Brain tumors, including malignant gliomas, present significant treatment challenges.
- Recurrent tumors often have limited therapeutic options after conventional irradiation.
- Advancements in imaging and stereotactic systems enable precise radiation delivery.
Purpose:
- To evaluate the efficacy of interstitial brachytherapy for treating brain tumors, particularly recurrent malignant gliomas.
- To compare outcomes of brachytherapy with conventional chemotherapy for recurrent malignant gliomas.
Summary:
- Interstitial brachytherapy utilizes CT-directed stereotaxic systems for precise implantation of iodine-125 sources directly into brain tumors.
- This technique allows for targeted irradiation of the tumor while minimizing dose to surrounding healthy brain tissue.
- The median survival for patients with recurrent malignant gliomas treated with brachytherapy was 74 weeks, significantly longer than the 36 weeks observed with chemotherapy.
Impact:
- Interstitial brachytherapy demonstrates a higher therapeutic ratio, enabling higher initial doses and reirradiation of recurrent tumors.
- This treatment modality offers a promising alternative for patients with recurrent malignant gliomas, improving survival outcomes.
- The precision offered by CT-directed stereotaxic systems enhances the safety and effectiveness of brain tumor brachytherapy.